Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: Role of extracellular Ca2+ and L-type Ca2+ channels

Brain Research

Volumn 1047, Issue 1, 2005, Pages 18-29

  Rocchitta, Gaia ^a   Migheli, Rossana ^a   Mura, Maria P ^a   Grella, Giuseppe ^a   Esposito, Giovanni ^a   Marchetti, Bianca ^a,b   Miele, Egidio ^a   Desole, Maria S ^a   Miele, Maddalena ^c   Serra, Pier Andrea ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Calcium channels; Complex; Exogenous nitric oxide; Iron; Parkinson's disease; Striatal dopamine release

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CONOTOXIN; DEFEROXAMINE; IMIDAZOLE DERIVATIVE; IRON; NIFEDIPINE; NITRIC OXIDE; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; COMPLEX FORMATION; CORPUS STRIATUM; DIALYSATE; DOPAMINE RELEASE; EXTRACELLULAR CALCIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BENZOATES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR FLUID; IMIDAZOLES; IRON; IRON CHELATING AGENTS; MALE; MICRODIALYSIS; MOVEMENT; NITRIC OXIDE; NITRIC OXIDE DONORS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; SORBITOL; SPIN LABELS; SYNAPTIC TRANSMISSION; THIOCARBAMATES; WAKEFULNESS;

EID: 20444410762     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.04.008     Document Type: Article

References (61)

1. •) production in an activated macrophage culture with a radical scavenger, carboxy PTIO and Griess reagent FEBS Lett. 368 1995 425 428
2. A.I. Boullerne, L. Nedelkoska, and J.A. Benjamins Synergism of nitric oxide and iron in killing the transformed murine oligodendrocyte cell line N20.1 J. Neurochem. 72 1999 1050 1060
3. P.S. Cahill, and R.M. Wightman Simultaneous amperometric measurement of ascorbate and catecholamine secretion from individual bovine adrenal medullary cells Anal. Chem. 67 1995 2599 2605
4. D. Centonze, P. Gubellini, A. Pisani, G. Bernardi, and P. Calabresi Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity Rev. Neurosci. 14 2003 207 216
5. L.A. Chiodo Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology Neurosci. Biobehav. Rev. 12 1988 49 91
6. M. Cossette, A. Parent, and D. Levesque Tyrosine hydroxylase-positive neurons intrinsic to the human striatum express the transcription factor Nurr1 Eur. J. Neurosci. 20 2004 2089 2095
7. C. Daveu, C. Servy, M. Dendane, P. Marin, and C. Ducrocq Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide Nitric Oxide 1 1997 234 243
8. S. Dudgeon, D.P. Benson, A. MacKenzie, K. Paisley-Zyszkiewicz, and W. Martin Recovery by ascorbate of impaired nitric oxide-dependent relaxation resulting from oxidant stress in rat aorta Br. J. Pharmacol. 125 1998 782 786
9. F. Feger, H. Ferry-Damazet, M. Mamani Matsuda, J. Bordenave, M. Dupouy, A.K. Nussle, M. Arock, L. Devevey, J. Nafzinger, J.J. Guillosson, J. Reiffers, and M.D. Mossalayi Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide Cancer Res. 61 2001 5289 5294
10. M.N. Friedemann, S.W. Robinson, and G.A. Gerhardt o-Phenylenediamine- modified carbon fiber electrodes for the detection of nitric oxide Anal. Chem. 68 1996 2621 2628
11. J. Garthwaite, and C.L. Boulton Nitric oxide signaling in the central nervous system Annu. Rev. Physiol. 57 1995 683 706
12. R. Guevara-Guzman, P.C. Emson, and K.M. Kendrick Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP J. Neurochem. 62 1994 807 810
13. J.M. Gutteridge, G.J. Quinlan, J. Swain, and J. Cox Ferrous ion formation by ferrioxamine prepared from aged desferioxamine: a potential pro-oxidant property Free Radical Biol. Med. 16 1994 733 739
14. H. Ischiropoulos, D. Duran, and J. Horwitz Peroxynitrite mediated inhibition of DOPA synthesis in PC12 cells J. Neurochem. 65 1995 2366 2372
15. T.S. Jackson, A. Xu, J.A. Vita, and J.F. Keaney Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations Circ. Res. 83 1998 916 922
16. K.A. Jellinger The role of iron in neurodegeneration. Prospect for pharmacotherapy of Parkinson's disease Drugs Aging 14 1999 11 140
17. V.E. Kagan, A.V. Kozlov, Y.Y. Tyurina, A.A. Shevdova, and J.C. Yalowich Antioxidant mechanism of nitric oxide against iron-catalysed oxidative stress in cells Antioxid. Redox Signal. 3 2001 189 202
18. S.A. Khan, and J.M. Hare The role of nitric oxide in the physiological regulation of Ca2+ cycling Curr. Opin. Drug Discovery Dev. 6 2003 658 666
19. C. Knott, G. Stern, and G.P. Wilkin Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2 Mol. Cell. Neurosci. 16 2000 724 739
20. R.G. Knowles, M. Palacios, R.M. Palmer, and S. Moncada Formation of nitric oxide from l-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase Proc. Natl. Acad. Sci. U. S. A. 86 1989 5159 5162
21. A.M. Komarov, I.T. Mak, and W.B. Weglicki Iron potentiates nitric oxide scavenging by dithiocarbamates in tissue of septic shock mice Biochim. Biophys. Acta 1361 1997 229 234
22. L.N. Kubrina, V.D. Mikoyan, P.I. Mordvintcev, and A.F. Vanin Iron potentiates bacterial lipopolysaccharide-induced nitric oxide formation in animal organs Biochim. Biophys. Acta 1167 1993 240 244
23. N.E. Le Brun, S.C. Andrews, G.R. Moore, and A.J. Thomson Interaction of nitric oxide with non-haem iron sites of Escherichia coli bacterioferritin: reduction of nitric oxide to nitrous oxide and oxidation of iron(II) to iron(III) Biochem. J. 326 1997 173 179
24. E. Lilley, and A. Gibson Release of the antioxidants ascorbate and urate from a nitrergically-innervated smooth muscle Br. J. Pharmacol. 122 1997 1746 1752
25. A.M. Lin Recovery by NO of the iron-attenuated dopamine dynamics in nigrostriatal system of the rat brain Neurosci. Res. 34 1999 133 139
26. A. Meir, S. Ginsburg, A. Butkevich, S.G. Kachalsky, I. Kaiserman, R. Ahdut, S. Demirgoren, and R. Rahamimoff Ion channels in presynaptic nerve terminals and control of transmitter release Physiol. Rev. 79 1999 1019 1088
27. M. Miele, and M. Fillenz In vivo determination of extracellular brain ascorbate J. Neurosci. Methods 70 1996 15 19
28. J. Millar The nitric oxide/ascorbate cycle: how neurones may control their own oxygen supply Med. Hypotheses 45 1995 21 26
29. K.P. Mohanakumar, I. Hanbauer, and C.C. Chiueh Neuroprotection by nitric oxide against hydroxyl radical-induced nigral toxicity J. Chem. Neuroanatom. 14 1996 195 205
30. M.C. Morale, P.A. Serra, M.R. Delogu, R. Migheli, G. Rocchitta, C. Tirolo, S. Caniglia, N. Testa, F. Gennuso, F. L'Episcopo, G.M. Scoto, N. Barden, E. Miele, M.S. Desole, and B. Marchetti Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system. Critical role of glial nitric oxide FASEB J. 18 2004 164 166
31. D.B. Morton, and P.H.M. Griffiths Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment Vet. Rec. 116 1985 431 436
32. 2+ channels on excessive dopamine release from rat caudate putamen Physiol. Behav. 68 2000 641 649
33. T. Oyoshi, M. Nomoto, H. Hirano, and J. Kuratsu Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry J. Pharmacol. Sci. 91 2003 15 22
34. G. Paxinos, and C. Watson Rat Brain in Stereotaxic Coordinates 1986 Academic Press San Diego
35. P.E. Phillips, and J.A. Stamford Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by regular and burst firing Brain Res. 884 2000 139 144
36. M.J. Porritt, P.E. Batchelor, A.J. Hughes, R. Kalnins, G.A. Donnan, and D.W. Howells New dopaminergic neurons in Parkinson's disease striatum Lancet 356 2000 44 45
37. P. Rauhala, K.P. Mohanakumar, I. Sziraki, A.M. Lin, and C.C. Chiueh S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo Synapse 23 1996 58 60
38. D.W. Reif, and R.D. Simmons Nitric oxide mediates iron release from ferritin Arch. Biochim. Biophys. 283 1990 537 541
39. M. Reiser, L. Schild, G. Keilhoff, and G. Wolf Interaction of nitric oxide donors and ascorbic acid on D-[3H] aspartate efflux from rat striatal slices Neurochem. Res. 24 1999 61 67
40. M.E. Rice Ascorbate regulation and its neuroprotective role in the brain Trends Neurosci. 23 2000 209 216
41. P. Riederer, and S. Wuketich Time course of nigrostriatal degeneration in Parkinson's disease J. Neural Transm. 38 1976 277 301
42. J. Rizo, and T.C. Südhof SNARES and MUNC18 in synaptic vesicle fusion Nat. Rev., Neurosci. 3 2002 641 653
43. G. Rocchitta, R.M. Delogu, R. Migheli, L. Solinas, G. Susini, M.S. Desole, E. Miele, M. Miele, and P.A. Serra On the mechanism of levosimendan-induced dopamine release in the striatum of freely moving rats J. Pharmacol. Sci. 95 2004 299 304
44. 2+ entry through store-operated channels Brain Res. 1023 2004 243 252
45. M. Rudeck, T. Volk, N. Sitte, and T. Grune Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome IUBMB Life 49 2000 451 456
46. P.A. Serra, G. Esposito, M.R. Delogu, R. Migheli, G. Rocchitta, G. Grella, E. Miele, M. Miele, and M.S. Desole Analysis of 3-morpholinosydnonimine and sodium nitroprusside effects on dopamine release in the striatum of freely moving rats: role of nitric oxide, iron and ascorbic acid Br. J. Pharmacol. 131 2000 836 842
47. P.A. Serra, G. Esposito, M.R. Delogu, R. Migheli, G. Rocchitta, E. Miele, M.S. Desole, and M. Miele Analysis of S-nitroso-N-acetylpenicillamine effects on dopamine release in the striatum of freely moving rats: role of endogenous ascorbic acid and oxidative stress Br. J. Pharmacol. 132 2001 941 949
48. P.A. Serra, G. Rocchitta, G. Esposito, M.R. Delogu, R. Migheli, E. Miele, M.S. Desole, and M. Miele A study on the role of nitric oxide and iron in 3-morpholinosydnonimine-induced increases in dopamine release in the striatum of freely moving rats Br. J. Pharmacol. 134 2001 275 282
49. P.A. Serra, L. Sciola, M.R. Delogu, A. Spano, G. Monaco, E. Miele, G. Rocchitta, M. Miele, R. Migheli, and M.S. Desole The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes J. Biol. Chem. 277 2002 34451 34461
50. P.A. Serra, R. Migheli, G. Rocchitta, M.G. Taras, M.P. Mura, M.R. Delogu, G. Esposito, E. Miele, M.S. Desole, and M. Miele Role of the nitric oxide/cyclic GMP pathway and ascorbic acid in 3-morpholino-sydnonimine (SIN-1)-induced increases in dopamine secretion from PC12 cells. A microdialysis in vitro study Neurosci. Lett. 353 2003 5 8
51. P.A. Serra, G. Rocchitta, M.R. Delogu, R. Migheli, M.G. Taras, M.P. Mura, G. Esposito, E. Miele, M.S. Desole, and M. Miele Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells. A microdialysis in vitro study J. Neurochem. 86 2003 1403 1413
52. D.D. Song, and S.N. Haber Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting J. Neurosci. 20 2000 5102 5114
53. J.S. Stamler, D.J. Singel, and J. Loscalzo Biochemistry of nitric oxide and its redox-activated forms Science 258 1992 1898 1902
54. J.S. Trimmer, and K.J. Rhodes Localization of voltage-gated ion channels in mammalian brain Annu. Rev. Physiol. 66 2004 477 519
55. K.Y. Tseng, F. Kasanetz, L. Kargieman, L.A. Riquelme, and M.G. Murer Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions J. Neurosci. 16 2001 6430 6439
56. K. Tsuchiya, M. Yoshizumi, M. Houchi, and R.P. Mason Nitric oxide- forming reaction between the iron-N-methyl-d-glucamine dithiocarbamate complex and nitrite J. Biol. Chem. 275 2000 1551 1556
57. A.F. Vanin, X. Liu, A. Samouilov, R.A. Stukan, and J.L. Zweier Redox properties of iron-dithiocarbamates and their nitrosyl derivatives: implications for their use as traps of nitric oxide in biological systems Biochim. Biophys. Acta 1474 2000 365 377
58. A.R. West, M.P. Galloway, and A.A. Grace Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms Synapse 44 2002 227 245
59. T. Yamamoto, K. Yuyama, K. Nakamura, T. Kato, and H. Yamamoto Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release Eur. J. Pharmacol. 397 2000 25 33
60. L. Zecca, M.B. Youdim, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat. Rev., Neurosci. 5 2004 63 73
61. X. Zhang, Y. Kislyak, J. Lin, A. Dickson, L. Cardosa, M. Broderick, and H. Fein Nanometer size electrode for nitric oxide and S-nitrosothiols measurement Electrochem. Commun. 4 2002 11 16